GGrantIndex
Sort

40,608 grants matching prostate cancer

Impact of Fn14-targeted Nanoparticles for Triple-Negative Breast Cancer

$330,244
Anthony J. Kim · University Of Maryland Baltimore · R37 · FY2024 · CA

PROSTATE CANCER, CALCIUM AND VITAMIN D

$330,190
University Of Notre Dame · R01 · FY2005 · CA

PROSTATE CANCER, CALCIUM AND VITAMIN D

$330,190
University Of Notre Dame · R01 · FY2003 · CA

PROSTATE CANCER, CALCIUM AND VITAMIN D

$330,190
University Of Notre Dame · R01 · FY2004 · CA

Biomarker Discovery & Validation for Early Localized Prostate Cancer Administrative Core

$330,184
Oliver John Semmes · Old Dominion University · U2C · FY2024 · CA

Project 1: Resistance caused by AR pathway reactivation

$330,155
Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2021 · CA

Chemistry and Spectroscopy of Copper Monooxygenases

$330,138
Ninian J Blackburn · Oregon Health & Science University · R01 · FY2012 · NS

Chemistry and Spectroscopy of Copper Monooxygenases

$330,138
Ninian J Blackburn · Oregon Health & Science University · R01 · FY2011 · NS

DUAL-MODALITY CONTRAST AGENTS FOR MRI AND MICRO-CT IMAGING OF PROSTATE CANCER

$330,101
University Of Washington · · FY2008 · Department of Defense

PSMA-based Cancer Imaging Agents

$330,091
Martin G Pomper · Johns Hopkins University · R01 · FY2012 · CA

MicroRNAs in Advanced Prostate Cancer: A miR-21 model

$330,091
Shawn Lupold · Johns Hopkins University · R01 · FY2012 · CA

MicroRNAs in Advanced Prostate Cancer: A miR-21 model

$330,091
Shawn Lupold · Johns Hopkins University · R01 · FY2011 · CA

PSMA-based Cancer Imaging Agents

$330,091
Martin G Pomper · Johns Hopkins University · R01 · FY2011 · CA

Mild hyperthermia to enhance delivery of therapeutic nanocarriers in tumors: imaging, in vivo study, and simulation

$330,061
Liang Zhu · University Of Maryland Baltimore County · · FY2017 · ENG

MnTE-2-PyP as a radioprotector in prostate cancer therapy

$330,057
Rebecca E Oberley-Deegan · University Of Nebraska Medical Center · R01 · FY2014 · CA

IMAGING PROSTATE CANCER WITH POSITRON EMISSION TOMOGRAPHY

$330,044
Wake Forest University Health Sciences · · FY2013 · Department of the Army

MI: MODULATING OSTEOCLAST GENE EXPRESSION AND FUNCTION

$330,000
Michael C Ostrowski · Ohio State University · R01 · FY2009 · AR

INCREASING ACCESS TO CLINICAL AND EDUCATIONAL STUDIES

$330,000
Thomas Jefferson University · U01 · FY2000 · CA

MI: MODULATING OSTEOCLAST GENE EXPRESSION AND FUNCTION

$330,000
Michael C Ostrowski · Ohio State University · R01 · FY2008 · AR

DNA methylation in aging, race and prostate cancer

$330,000
Northern California Institute Res &Educ · R01 · FY2005 · AG

DNA methylation in aging, race and prostate cancer

$330,000
Northern California Institute Res &Educ · R01 · FY2004 · AG

Engineered HGF-NK1 antagonists for Met-targeted cancer imaging and therapy

$329,990
Jennifer R Cochran · Stanford University · R01 · FY2010 · CA

HORMONES: BIOCHEMISTRY AND MOLECULAR BIOLOGY

$329,977
Max Elliot Gottesman · Columbia University Health Sciences · T32 · FY2012 · DK

Role of PTEN in Chromosome Segregation and its Importance for Tumor Suppression

$329,925
Jan M. Van Deursen · Mayo Clinic Rochester · R01 · FY2012 · CA

Elucidating a novel molecular biomarker for castration-resistant prostate cancer

$329,925
Nima Sharifi · Ut Southwestern Medical Center · R01 · FY2012 · CA